Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group

Ähnliche Einträge

• Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis
  von: Victoria Murillo, et al.
  Veröffentlicht: (2024)
• Avatrombopag for post‐transplant thrombocytopenia following allogeneic haematopoietic stem cell transplantation: A single‐centre retrospective study
  von: Cristian Alberdi‐Lema, et al.
  Veröffentlicht: (2026)
• Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation
  von: Francesca Perutelli, et al.
  Veröffentlicht: (2025)
• Clinical perspectives on post‐induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation
  von: Kendra Sweet, et al.
  Veröffentlicht: (2024)
• Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013–2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy
  von: Takaaki Konuma, et al.
  Veröffentlicht: (2025)